Coates, L., Garrood, T., Gullick, N., Helliwell, P., Kent, T., Marks, J., . . . McInnes, I. (2022). Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PSA-1 and SELECT-PsA-2 trials assessed according to modified PsARC. Oxford University Press.
Citace podle Chicago (17th ed.)Coates, LC, et al. Upadacitinib Response Rates in Patients with Psoriatic Arthritis Enrolled in the SELECT-PSA-1 and SELECT-PsA-2 Trials Assessed According to Modified PsARC. Oxford University Press, 2022.
Citace podle MLA (9th ed.)Coates, LC, et al. Upadacitinib Response Rates in Patients with Psoriatic Arthritis Enrolled in the SELECT-PSA-1 and SELECT-PsA-2 Trials Assessed According to Modified PsARC. Oxford University Press, 2022.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..